Trials / Completed
CompletedNCT02113865
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
Obtención de un Panel de puntuación ("Score System") Para la predicción de Riesgo Individualizado y la detección Precoz de Carcinoma Hepatocelular (HCC) en Sujetos Coinfectados VIH/VHC
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to establish a clinical score panel based on clinical, molecular and genetic parameters that allow us to stratify and obtain an early detection of patients with an increased risk of developing hepatocellular carcinoma (HCC).
Detailed description
Transversal study design like a "proof of concept". Primary objective: The main objective is try to stablish a descriptive panel (first phase of a score system) based in the conjunction or sum of several clinical and laboratory parameters (molecular and genetic factors). The aim is to detect in a fast, early and successful way those patients that presents a high risk to develop an hepatocellular carcinoma (HCC) in the future in a specific population: HIV and HCV coinfected patients. The establishment of this panel will allow clinicians set up a correct treatment decreasing the probability of liver cirrhosis and HCC.
Conditions
- Acquired Immunodeficiency Syndrome Virus
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
- Hepatocellular Carcinoma
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-10-01
- Completion
- 2015-02-01
- First posted
- 2014-04-15
- Last updated
- 2015-03-09
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02113865. Inclusion in this directory is not an endorsement.